0001181431-11-026368.txt : 20110502 0001181431-11-026368.hdr.sgml : 20110502 20110502173135 ACCESSION NUMBER: 0001181431-11-026368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110428 FILED AS OF DATE: 20110502 DATE AS OF CHANGE: 20110502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DePinho Ronald A CENTRAL INDEX KEY: 0001486420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 11802133 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172995000 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 rrd309893.xml DEPIHNO FORM 4 X0303 4 2011-04-28 0 0001325879 AVEO PHARMACEUTICALS INC AVEO 0001486420 DePinho Ronald A C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2011-04-28 4 S 0 10000 14.6958 D 240012 D Common Stock 2011-04-28 4 S 0 10000 15.5258 D 230012 D Common Stock 2011-04-28 4 S 0 10000 14.6938 D 232512 I by spouse Common Stock 2011-04-28 4 S 0 10000 15.5279 D 222512 I by spouse This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2011. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $14.88, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $15.59, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 8, 2011. These shares are held by the reporting person's spouse. The reporting person disclaims all beneficial ownership over all such shares, except to the extent of his pecuniary interest therein. /s/ Joseph D. Vittiglio, attorney-in-fact 2011-05-02